Agenda – Digital Therapeutics Summit

  • Day One
  • Day Two

Day One

 Monday, November 4

8:45AM – 9:00AM

Co-Chairperson’s Opening Remarks
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Senior Director of Investments, SANOFI VENTURES

9:00AM – 9:40AM

KEYNOTE ADDRESS
Take a Deep Dive: Change, Adoption, and Innovation in the Digital Therapeutics Industry

Jennifer Goldsack, Interim Executive Director, DIME SOCIETY

 MARKET ACCESS

9:40AM – 10:20AM

STAKEHOLDER PANEL
Digital Therapeutics: The NEW Commercial Model

Mette Dyhrberg, Founder and CEO, MYMEE
Savan Devani, Founder and CEO, BIOTRILLION

10:20AM – 10:50AM

Networking Break

10:50AM – 11:30AM

Looking Ahead: Exploring Regulatory Pathways for Digital Therapeutics
Martin Culjat, SVP Scientific and Regulatory Affairs, DTHERA SCIENCES

11:30AM – 12:10PM

Leveraging a Digital Therapeutic Patient Platform: Managing and Treating Patients With Sanofi
Chris Wasden, Ed.D., Head, Pharma, HAPPIFYDTX

12:10PM – 1:10PM

Luncheon

1:10PM – 1:50PM

Lessons Learned: Partner With Clinicians for Digital Therapeutics Integration
Barbara Eichorst, Global Diabetes and Digital Therapeutics Clinical Liaison, VOLUNTIS
Laurel Fuqua, Executive VP and Chief Clinical Officer, MONARCH MEDICAL TECHNOLOGIES

 PARTNERSHIPS

1:50PM – 2:30PM

Lessons Learned: The Many Journeys to Partnership
Adam Kaufman, President and CEO, CANARY HEALTH

2:30PM – 3:00PM

Networking Break

3:00PM – 3:40PM

Partnering to Enable New Business Models: The Need for Novel Partnership Modalities
Vincent Hennemand, SVP, Corporate and Business Development, AKILI INTERACTIVE LABS
TBD, SHIONOGI

3:40PM – 4:20PM

Collaborating With a Payer: Explore the Process From Medical Policy to Commercialization
Debra Reisenthel, Founding CEO, Freespira Digital Therapeutic, PALO ALTO HEALTH SCIENCES
Matthew Tucker, Director of Strategy and Innovation, HIGHMARK HEALTH


Day Two

 Tuesday, November 5

8:00AM – 8:45AM

Continental Breakfast

8:45AM – 9:00AM

Co-Chairpersons’ Recap of Day One
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Senior Director of Investments, SANOFI VENTURES

9:00AM – 9:40AM

Strategic Partnerships: Establishing Necessary Ingredients To Successfully Improve Patient Outcomes With Digital Therapeutics
Owen McCarthy, Co-Founder and President, MEDRHYTHMS
Carlos Rodarte, SVP Life Sciences Strategy and Business Development, HEALTH CATALYST

 DATA & VALIDATION

11:00AM – 11:30AM

Networking Break

11:30AM – 12:10PM

Payer Perspective: Digital Therapeutics Validation
Mark Bini, Vice President, Innovation and Member Experience, EXPRESS SCRIPTS

12:10PM – 12:50PM

Real-World Evidence: Understand the Value of Developing RWE in Digital Therapeutics
Veera Anantha, Founder, CTO and President, THE LEARNING CORP

12:50PM – 1:50PM

Luncheon

2:30PM – 3:10PM

Understanding Challenges and Creating Solutions: Build a Body of Clinical Evidence for Digital Solutions
Suzanne Sysko Clough, M.D., Chief Medical Officer, AMALGAMRX
Ryan Sysko, CEO, AMALGAMRX

3:50PM – 4:00PM

Co-Chairpersons’ Closing Remarks
Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
Ruchita Sinha, Senior Director of Investments, SANOFI VENTURES